You have 9 free searches left this month | for more free features.

ifosfamide

Showing 26 - 50 of 260

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in China (MASCT-I, Ifosfamide, PD1 antibody)

Recruiting
  • Advanced Solid Tumors
  • MASCT-I
  • +6 more
  • Beijing, Beijing, China
  • +8 more
Dec 29, 2022

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Unresectable Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Unresectable Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
  • Hodgkin's Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020

Extranodal NK-T-Cell Lymphoma Trial in Seoul (Etoposide, Ifosfamide, Dexamethasone)

Unknown status
  • Extranodal NK-T-Cell Lymphoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
  • +1 more
Oct 21, 2020

Lymphoma Trial in Worldwide (cyclophosphamide, cytarabine, dexamethasone)

Completed
  • Lymphoma
  • Vienna, Austria
  • +9 more
May 24, 2022

Pleuropulmonary Blastoma Trial in Minneapolis (Vincristine, Dactinomycin, Cyclophosphamide)

Active, not recruiting
  • Pleuropulmonary Blastoma
  • Minneapolis, Minnesota
    Anne K Harris
May 26, 2021

Sarcoma Trial in Los Angeles (sorafenib, Ifosfamide)

Terminated
  • Sarcoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Sarcoma Trial in New York (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • filgrastim
  • +10 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 5, 2021

Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in

Completed
  • Pleomorphic Rhabdomyosarcoma
  • +3 more
  • Epirubicin Hydrochloride
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 23, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

Terminated
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +76 more
Nov 7, 2022

Kidney Cancer Trial in France (doxorubicin HCl, ifosfamide)

Completed
  • Kidney Cancer
  • doxorubicin hydrochloride
  • ifosfamide
  • Avignon, France
  • +13 more
Feb 18, 2021

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Ifosfamide
  • +13 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021

Germ Cell Tumors Trial in France (Paclitaxel, Ifosfamide, Carboplatine)

Completed
  • Germ Cell Tumors
  • Angers, France
  • +11 more
Jan 11, 2021

Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)

Recruiting
  • Sarcoma, Soft Tissue
  • Shanghai, Shanghai, China
    Fudan University, Cancer Hospital
Jul 13, 2020

Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)

Terminated
  • Locally Advanced Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 5, 2021

Effect of Drugs, Progression, Pediatric Cancer Trial in Beijing (Famitinib, Ifosfamide, Camrelizumab)

Withdrawn
  • Effect of Drugs
  • +2 more
  • Beijing, Beijing, China
    Lu Xie
May 15, 2020

Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor Trial in Villejuif (carboplatin, cisplatin, cyclophosphamide)

Completed
  • Extragonadal Germ Cell Tumor
  • Testicular Germ Cell Tumor
  • Villejuif, France
    Institut Gustave Roussy
Feb 19, 2021

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023

Germ Cell Tumor Trial in Bratislava (Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Germ Cell Tumor
  • Bratislava, Slovakia
    National Cancer Institute
Aug 5, 2020

Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  • Vancouver, British Columbia, Canada
    BC Cancer Agency
Jul 20, 2021

Hodgkin Disease Trial in Belgium, France (Brentuximab Vedotin, Etoposide, Carboplatine)

Completed
  • Hodgkin Disease
  • Brentuximab Vedotin
  • +3 more
  • Bruxelles, Belgium
  • +18 more
Dec 6, 2021